Paris [France], June 19 (ANI): Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the COVID-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCG
Moscow [Russia], April 2 (ANI): Russian Health Ministry has registered the nasal version of Sputnik V, the world's first nasal vaccine against COVID-19.
Washington [US], March 26 (ANI): Saliva samples can identify COVID-19 more quickly than testing with nasal swabs, suggests a recent study led by the American Society for Microbiology.
Washington [US], March 22 (ANI): According to a study led by the American Society for Microbiology, saliva samples can identify COVID-19 more quickly than testing with nasal swabs.
Mumbai (Maharashtra) [India], February 9 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark) - a global, innovation-driven pharmaceutical company and Canadian pharmaceutical company SaNOtize Research & Development Corp., today announced launch of its Nitric Oxide Nasal Spray un
New Delhi [India], February 9 (ANI): Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for treatment of adult patients suffering from COVID-19.
New Delhi [India], January 30 (ANI): As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay
Washington [US], January 30 (ANI): A new study has developed an influenza vaccine that is administered through the nose and has been constructed with nanoparticles that increase the immune response and offers stronger protection.
Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven, global, integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Lot
Mumbai (Maharashtra) [India], January 14 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited, a research-led, global integrated pharmaceutical company announced that its fully owned subsidiary Glenmark Specialty S.A. (Switzerland), received FDA approval on its New Drug Application (NDA) fo
New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
New Delhi [India], December 25 (ANI): Prime Minister Narendra Modi on Saturday said that the nasal vaccine and the world's first DNA vaccine against the COVID-19 will soon be available for the inoculation drive.